Novel Biologic Agents for Multiple Sclerosis and Their Impact on Managed Care

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system that is associated with progressive disability and cognitive dysfunction. Advances in our understanding of MS pathogenesis and DNA technology have led to the development of several novel biologic agents that tar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Formulary (Cleveland, Ohio) Ohio), 2004-11, p.15
Hauptverfasser:	Chao, Schumarry H, Smith, Craig H
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Blood-brain barrier Cell adhesion & migration Clinical trials Disease Disease management Drug therapy FDA approval Immunotherapy Inflammatory diseases Leukocytes Lymphocytes Magnetic resonance imaging Medicare Prescription Drug Improvement & Modernization Act 2003-US Monoclonal antibodies Multiple sclerosis Nervous system Pathogenesis Pathology Prescription drugs Psoriasis Rheumatoid arthritis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!